New Indian office opens
Phenomenex has expanded its international subsidiary network to serve India directly from a new office in Hyderabad, India.
Phenomenex has expanded its international subsidiary network to serve India directly from a new office in Hyderabad, India. According to the company, the new entity will serve research communities throughout India with sales and service teams that sell all of the company’s products directly and provide timely technical support, training and seminars.
“Phenomenex India will provide our growing customer base with the most innovative products along with fast deliveries, expert technical support and outstanding service,” commented Fasha Mahjoor, company president. “We are proud to continue the expansion of our international operations, which serve customers worldwide.”
The company reports that all products, including the leading Luna, Gemini, Synergi, Kinetex, Strata-X, BioSep, Lux and Zebron brands, will be supplied exclusively from the new office to customers in India.
For more information on Phenomenex, visit www.phenomenex.com
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
